Oakdale, MN – According to filings with the U.S. Securities and Exchange Commission, CranioVation is raising $16,000,000.00 in new funding. Sources indicate as part of senior management Chief Executive Officer, Vijay Agarwal played a key role in securing the recent investment and it will aid in aggressively expanding the company, as well as broaden and accelerate product development.

About CranioVation

CranioVation has developed an innovative solution to treat aggressive brain tumors using light delivered via a minimally invasive device, allowing patients to avoid undergoing invasive brain surgery.  Our novel device utilizes photodynamic therapy, a treatment which uses light to kill cancer cells which have been exposed to a photosensitizer, a safe and naturally occurring compound that is already approved by the FDA.  Once the patient drinks the photosensitizer, it selectively accumulates in tumor cells.  When the tumor cells are exposed to light of a particular wavelength, they undergo cell death, leaving healthy brain tissue completely intact.

To learn more about CranioVation, visit http://www.craniovation.com/

Contact:
Vijay Agarwal, Chief Executive Officer
310-413-4338

SOURCE: http://www.intelligence360.io
Copyright (c) 2020 SI360 Inc. All rights reserved